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Objectives. The objective of this study was to comparatively evaluate the density of lymphatic vessels (LVD) and neoformed
microvessels (NMVD) in squamous cell carcinoma of the oral cavity (OCSCC) and lip (LSCC). Association between
LVD/NMVD and vascular endothelial growth factor (VEGF)-A/-C was also assessed.
Study Design. OCSCC and LSCC were compared with regard to immunoexpression of LVD, NMVD, and vascular endothelial
growth factor-A (VEGF)-A/-C. Association between VEGF-A/-C with vascularity was also assessed. Statistical analyses were
performed using t test, Pearson 2, and Mann-Whitney tests. Statistical significance was accepted at P less than .05.
Results. The NMVD and VEGF-C expressions were significantly higher in OCSCC compared with LSCC. NMVD was
associated with VEGF-C in OCSCC, but not in LSCC.
Conclusions. Differences in NMVD and VEGF-C were found between OCSCC and LSCC. Positive association between VEGF-
C and NMVD was observed in OCSCC, but not in LSCC, which may be one of the contributing factors that account for the
distinctive clinical-biological behavior of these lesions. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:391-398)Oral squamous cell carcinoma (OSCC) is the most
common malignant tumor of the head and neck re-
gion1,2 and it can affect both the oral cavity (OCSCC)
and lip vermilion (LSCC).3 The main risk factors re-
lated to OCSCC are the use of tobacco and the abuse of
alcohol,4,5 whereas chronic exposure to ultraviolet
(UV) radiation is the most frequent etiologic factor
involved in LSCC development.3,6 OCSCC and LSCC
present distinct clinical and microscopic characteristics
that reflect on their biological behavior and prognosis.5
OCSCC is characterized by a high rate of local invasion
and cervical metastasis, which directly affects the prog-
nosis of patients.3,5,7 Conversely, patients with LSCC
usually have a lower rate of node metastasis and a good
prognosis.5,8 A recent study published by our group
showed that LSCC is predominantly grade I according
to the World Health Organization (WHO), whereas
most OCSCC was grade III.5 We also observed that
OCSCC demonstrated a higher cell proliferation index
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doi:10.1016/j.tripleo.2011.08.010and a lower expression of apoptotic markers compared
with LSCC5; however, all of the parameters involved in
the distinct behavior of these diseases is not completely
understood.
Tumor angiogenesis and lymphangiogenesis play a
critical role in the growth and systemic dissemination
of different types of malignant tumors.9,10 A positive
relationship between vessel density and a worse prog-
nosis in head and neck cancer has been demonstrated,11
and a higher vascularity has been associated with me-
tastasis, advanced tumor stage, and a poor prognosis in
oral cancer.2,12-14
Vascular endothelial growth factor-A (VEGF-A) is a
member of the vascular endothelial growth factor
(VEGF) family and plays essential roles in vasculogen-
esis and angiogenesis. It’s crucial role in tumor angio-
genesis and blood-borne metastasis has been docu-
mented in a variety of cancers.9 Another member of the
VEGF family, VEGF-C, induces the growth of both
lymphatic and blood vessels in carcinomas and pro-
motes the proliferation, migration, and survival of the
cultured human adult lymphatic endothelium.15 An in-
creased expression of VEGF-C accelerates lymphatic
invasion and lymph node metastasis in experimental
tumors16 and in a variety of human cancers.17 Notably,
it was previously reported that VEGF-C is a major
modulator of lymphatic vessel density (LVD) and neo-
formed microvessel density (NMVD) in tumors2. The
anti-D2-40 antibody detects a fixation-resistant epitope
on podoplanin, which is a selective marker for the
lymphatic endothelium, allowing the identification of
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of neoangiogenesis and it has been used to identify
NMVD in different types of human cancers, such as
oral, prostate, and breast.2,19,20
In this context, some publications have demonstrated
a possible influence of LVD and NMVD in the prog-
nosis of OSCC,2,12-14 but no investigations have been
undertaken to comparatively analyze angiogenesis and
lymphangiogenesis and the growth factors related to
them in lip and oral cavity cancers. Thus, considering
the clinicopathological differences observed in these
lesions, in this study we comparatively evaluated LVD
(D2-40 vessels) and NMVD (CD105 vessels) in
samples of OCSCC and LSCC. In addition, the expres-
sions of VEGF-A and -C and the association between
these growth factors with vessel density were assessed
in these groups.
MATERIAL AND METHODS
Samples
This study was approved by the institutional ethics
committee for human subjects. The samples in this
retrospective study consisted of surgically excised
specimens from 26 patients with primary OCSCC and
21 patients with primary LSCC, obtained from the
Anatomopathology Division of Araujo Jorge Hospital,
Association of the Combat of Cancer of Goias State,
Brazil. Clinical data (gender, age, ethnic group, tobacco
and alcohol consumption, tumor location, and tumor
size) and follow-up information (survival data and
death) were obtained from medical records. The inclu-
sion criteria during this study were patients of both
genders, older than 35, T2/T3 primary tumor size,
WHO21 grade I/II, and a minimum follow-up of 48
months. The exclusion criteria were patients with SCC
in other sites, those without clinical history, and those
who received radiotherapy, chemotherapy, or any other
treatment before surgery. Eight samples of clinically
healthy alveolar mucosa collected during third molar
removal and 9 samples of normal lip mucosa\skin near
the lip were used as the control groups for comparative
evaluation of vessel density.
Light microscopy
All specimens were fixed in 10% buffered formalin (pH
7.4) and were paraffin embedded. The microscopic
features were evaluated from the analysis of one 5-m
section of each sample, stained with hematoxylin and
eosin. All of the SCC sections were graded according to
the WHO classification of tumors.
Immunohistochemistry
Paraffin-embedded tissues were sectioned (3 m) and
collected in serial sections on glass slides coated with2% 3-aminopropyltriethylsilane (Sigma-Aldrich, St.
Louis, MO). The sections were deparaffinized by im-
mersion in xylene, and this was followed by immersion
in alcohol and then incubation with 3% hydrogen per-
oxide diluted in Tris-buffered saline (TBS) (pH 7.4) for
40 minutes. For antigen retrieval, the sections were
immersed in citrate buffer (pH 6.0; Sigma) at 95°C for
20 minutes (for anti-D2-40, anti-VEGF-A, and anti-
VEGF-C) or incubated with pepsin for 13 minutes in a
37°C stove (for anti-CD105). Afterward, the sections
were blocked by incubation with 3% normal goat serum
for 20 minutes. The slides were incubated with one of
the following antibodies: monoclonal mouse anti-hu-
man VEGF-A (clone VG-1; 53,462; Santa Cruz Bio-
technology, Santa Cruz, CA) at 1:100; polyclonal rabbit
anti-human VEGF-C (clone VEGF-C; 182,255; Invit-
rogen, Camarillo, CA) at 1:100; monoclonal mouse
anti-human D2-40 (clone D2-40, Dako Cytomation,
Carpinteria, CA) at 1:100; and monoclonal mouse anti-
human endoglin (anti-CD105) (clone SN6h, DakoCy-
tomation, CA) at 1:30. The slides incubated with anti-
D2-40, anti-CD105, and anti-VEGF-C were maintained
at room temperature for 1 hour in a humidified cham-
ber. The slides incubated with anti-VEGF-A were
maintained at 4°C overnight in a humidified chamber.
After washing in TBS, the sections incubated with
anti-D2-40 and anti-CD105 were treated with Advance
Link System-HRP (Dako, Glostrup, Denmark); the sec-
tions incubated with anti-VEGF-A were treated with
the EnVision  Dual Link System-HRP (Dako); and
the sections incubated with anti-VEGF-C were treated
with labeled streptavidin-biotin (LSAB) kits (K0492,
Dako). The slides were then incubated in 3,3=-diamino-
benzidine in a chromogen solution (Dako) for 2 to 5
minutes at room temperature. Finally, the sections were
stained with Mayer’s hematoxylin and were covered.
Negative controls were obtained by the omission of
primary antibodies, which were substituted by 1%
phosphate-buffered saline–bovine serum albumin and
by nonimmune rabbit (X0902, Dako) or mouse
(X501-1, Dako) serum. The external positive control
for VEGF-A and -C was cancer cells of archived sam-
ples of breast adenocarcinoma. The positive control
was internal for D2-40 and CD105.
Cell counting and statistical analysis
The density (per mm2) of lymphatic vessels (D2-40
cells) and neoformed microvessels (CD105 cells) in
the intratumoral region were determined according to
the method described by Weidner et al.22 First, all
slides were screened using a low-magnification objec-
tive lens (100) to identify the areas that contained the
highest number of positively stained vessels (hot spots).
The number of vessels was counted in 3 fields in the hot
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ber of vessels from the 3 fields for each of the lym-
phatic vessels and the neoformed vessels were con-
verted into the number of vessels per mm2 area and
were defined as LVD and NMVD, respectively.
The expression of both VEGF-A and -C were deter-
mined separately by the percentage of positively
stained tumoral and stromal cells. Percentages greater
than 50% of VEGF cells were considered positive,
whereas percentages of 50% or lower were considered
negative. Descriptive analyses were expressed as mean
SD of n observations/mm2. Comparative analyses were
performed using the Student t test and the Mann-Whit-
ney test. The association between LVD/NMVD and
VEGF-A/-C was analyzed by using Pearson 2 test.
The level of statistical significance was accepted at P
less than .05.
RESULTS
The main clinical and microscopic features of our series
of 26 patients with OCSCC and 21 patients with LSCC
Table I. Main clinical findings (%) of patients with
OCSCC (n  26) and LSCC (n  21)
Clinical features OCSSC LSCC
Age
60 y 50% 34%
60 y 50% 66%
Gender
Male 73% 62%
Female 27% 38%
Ethnic groups
Caucasian 61% 62%
Non Caucasian 39% 38%
Location
Oral tongue 34% —
Floor of the mouth 20% —
Superior lip — 10%
Inferior lip — 90%
Others 46% —
Tobacco
Yes 100% 43%
No 0% 57%
Alcohol
Yes 65% 24%
No 35% 76%
Clinical outcome
Dead 31% 0%
Alive (overall survival) 69% 100%
Survival time
Alive: 48 mo 16% 100%
Alive: 48 mo 84% 0%
Metastasis
Yes 58% 0%
No 42% 100%
OCSCC, squamous cell carcinoma of the oral cavity; LSCC, squa-
mous cell carcinoma of the lip.are summarized in Table I.The immunohistochemical analysis revealed that
D2-40 and CD105-positive vessels (Fig. 1, A and B)
presented endothelial cell membrane staining. The
hot spots were concentrated in the intratumoral re-
gion.
A comparative analysis between clinically healthy
alveolar mucosa and lip normal mucosa\skin near the
lip showed that NMVD and LVD were not statistically
different between these groups (P  .05). In addition,
the expression of VEGF-A and -C was similar between
these groups (P  .05).
Our results revealed that the NMVD was signifi-
cantly greater in OCSCC (22.83  12.80) compared
with LSCC (12.33  9.96) (P  .02). The LVD was
similar in both groups (12.89  9.31 and 13.74 
11.04, in OCSCC and LSCC, respectively) (P  .8).
According to the results of VEGF-A and -C immu-
nohistochemical staining, the expression of both was
mainly identified in the cytoplasm of neoplastic and
stromal cells. In relation to VEGF-A, 81.50% and
51.85% of OCSCC samples were positive in the tumor
parenchyma and stroma, respectively, whereas 100%
and 72% of LSCC samples were positive in the tumor
parenchyma and stroma, respectively. We also ob-
served that 89% and 63% of OCSCC cases were
VEGF-C positive for tumor parenchyma and stroma,
respectively, and 63.7% and 9.1% of LSCC samples
were positive for VEGF-C in tumor parenchyma and
stroma, respectively (Fig. 1, C–F). Just one sample of
OCSCC was VEGF-C negative in the tumor paren-
chyma.
The expression of VEGF-A in the parenchyma and
stroma was not significantly different between the
groups, but there was a tendency for a higher expres-
sion in LSCC when compared with OCSCC. The ex-
pression of VEGF-C was significantly higher in OC-
SCC parenchyma and stroma than in LSCC (P  .046
and P  .00, respectively) (Fig. 2).
A positive association between VEGF-C expression
and NMVD was observed in OCSCC, but not in LSCC
(Fig. 3, A and B). We found a higher NMVD in the
VEGF-C–positive group in the tumor parenchyma of
OCSCC (median  22.67) when compared with the
VEGF-C–positive group in the tumor parenchyma of
LSCC (median  10.00) (Fig. 3, A).
Our results also showed a higher NMVD in the
VEGF-C–positive group in the tumor stroma of OC-
SCC (median  27.67) compared with LSCC
(NMVD  0.0) (Fig. 3, B). The findings demon-
strated that one sample of LSCC was VEGF-C pos-
itive in the peritumoral stroma and it presented
NMVD  0.0. There was no further association
between NMVD and VEGF-A.
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OCSCC and LSCC are distinct lesions and it is sug-
gested that their etiology is different. Oral cavity SCC
is a disease with a poor prognosis because it often
Fig. 1. NMVD (CD105 vessels) (arrows) (A and B) in
expression (brown stains) in tumor parenchyma (C and E) an
F). Immunohistochemical staining; original magnification shows nodal metastasis and can lead to patient death.On the other hand, patients with LSCC usually have a
better prognosis and a lower rate of regional lymph
node metastasis.3,5,7 UV radiation plays an important
role in LSCC development, whereas tobacco smoke
ratumoral region in OCSCC (A) and LSCC (B). VEGF-C
r stroma (D and F) in OCSCC (C and D) and LSCC (E and
-F).the int
d tumoand alcohol abuse, which are strongly synergic, are the
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SCC.3,5,7,8 In line with this, all patients with OCSCC in
this study smoked and most of them used alcohol in
association. We also observed that no patients with
LSCC presented cervical lymph node metastasis or
died, whereas approximately 60% of the OCSCC pa-
tients underwent regional metastasis and 31% of them
died. It is still not clear whether or not these etiologic
factors are responsible for the great variability in the
Fig. 2. The expression of VEGF-A was not significantly di
higher in OCSCC parenchyma and stroma than in LSCC (P
difference in LSCC group when compared with OCSCC.
Fig. 3. The association between VEGF-C expression in tumo
OCSCC and LSCC.prognosis of these lesions. Despite this, although all ofthe factors and events involved in the distinct behavior
between these diseases are not completely understood,
it has been suggested that a higher vascularity is in-
volved in a worse prognosis in head and neck11 and oral
cancer.2,12-14
Angiogenesis has been implicated in the growth and
progression of various human tumors.2,9,10 This process
is initiated by the up-regulation of proangiogenic fac-
tors, such as VEGF, and the down-regulation of anti-
between the groups. VEGF-C expression was significantly
6 and P  .00, respectively). Asterisk represents significant
chyma (A) and stroma (B) and NMVD (CD105 vessels) infferent
 .04r parenangiogenic factors. VEGF is not only involved in an-
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of tumor cell motility, metalloproteinase secretion, and
the augmentation of vascular permeability, favoring the
occurrence of metastasis. Bearing this in mind, it is
expected that increased VEGF expression will be a
common find in tumors with a poor prognosis.23
Here, we demonstrated for the first time, no differ-
ence in relation to vessel density between normal oral
cavity mucosa and lip mucosa, and we found a signif-
icantly higher NMVD (CD105 microvessels) in OC-
SCC compared with LSCC. The reason for this differ-
ence could be found in the relationship between
OCSCC and smoke. Because nicotine acts to induce
VEGF, it also participates in the formation of
NMVD.24 The presence of carcinogens and procarcino-
gens in tobacco could lead to tissue hypoxia via the
accumulation of hypoxia-inducible factor-1	 (HIF-1	),
causing a deficiency in the supply of oxygen.25 Never-
theless, some tumors continue to grow and invade
because of their adaptation to hypoxia through angio-
genesis, resulting in tumors with a high level of vascu-
larity.25 This higher vascularization in OCSCC com-
pared with LSCC observed in our study was evidenced
by the protein CD105, which is also up-regulated by
hypoxia,26 and which could justify the higher NMVD
found in OCSCC. Therefore, tobacco seems to be an
important modulator in the prognosis of oral cancer.
In the present study, VEGF-C expression was signif-
icantly higher in OCSCC than in LSCC. In line with
this, Kyzas et al.11 found a higher expression of VEGF
in neoplastic cells of SCC of the oral cavity and of the
larynx compared with SCC of the lip. As already cited,
the main etiologic factor for OCSCC is smoking; nic-
otine, one of the many substances released by tobacco
smoke, is a potent inducer of VEGF production.24 An
interesting fact is that UV radiation is also an inducer of
VEGF expression.27 Here, we also found that VEGF-A
was abundant in lip and oral cavity cancers, indicating
that both nicotine and UV radiation can enhance its
production, but these factors probably act in different
ways. Nevertheless, as VEGF-C expression was more
prevalent in OCSCC than in LSCC, we believe that
nicotine represents a more powerful and specific in-
ducer of VEGF-C than UV radiation. Another factor
that is probably involved in the higher expression of
VEGF-C in the OCSCC group is the hypoxia generated
by smoke. Nicotine stimulates HIF-1	 protein accumu-
lation and VEGF expression in non–small cell lung
cancer and it has been found that HIF-1	 contributes, at
least in part, to tumor angiogenesis by lung cancer
cells.25 Kyzas et al.28 demonstrated a correlation be-
tween HIF-1	 and VEGF in head and neck cancer.
Liang et al.29 showed that HIF-1	 correlates with
VEGF-C overexpression and lymphangiogenesis/an-giogenesis in oral SCC. Thus, VEGF-C may be an
important factor in the determination of different be-
haviors observed between these different anatomical
sites of oral SCC.
The measurement of vascular density has been ap-
plied in the prognosis prediction of various human
tumors with variable success. Some authors found a
lack of reliability in the determination of prognosis
when pan-endothelial markers were used.10 Currently,
specific endothelial-type antibodies, such as anti-
CD105 and anti-D2-40, seem to be more accurate for
this purpose. Endoglin (CD105) has been associated
with endothelial cell proliferation and is considered to
be a powerful marker of neovascularization in solid
malignant tumors.13
It has been suggested that lymphatic networks, which
vary between different anatomical sites, may influence
tumor evolution and outcome.7 Lymphatic vessels pro-
vide easier access for cancer cells to the lymphatic
system and, hence, raise the opportunity for lymphatic
spread. Thus, considering the fact that OCSCC shows
higher rates of nodal metastasis, we expected to find
increased intratumoral LVD in this location compared
with LSCC. We observed, however, that LVD was
similar in both groups. This absence of difference in
LVD could indicate that, besides not having a value in
differentiating oral cavity from lip SCC, it is not a good
prognosis marker for these kinds of cancer. Further-
more, it is also questionable whether lymphangiogen-
esis occurs in tumors.10 Most likely, the gain of an
aggressive phenotype is a more important event in
metastasis than the density of the lymphatic vascular
bed. Furthermore, although some authors have found a
correlation between LVD and VEGF-C in oral can-
cer,30 no relationship was observed by us between
VEGF-C expression and LVD, indicating that these
lymphatic vessels, highlighted by immunohistochemis-
try, could preexist before the appearance of tumor, as
speculated before.10
On the other hand, the expression of VEGF-C posi-
tively correlated with NMVD in OCSCC, indicating
that it has a possible role in the formation of new
vessels; however, this correlation was not found in
LSCC. Here, the marker used for NMVD was CD105,
which identifies neoformed microvessels in different
types of human cancers.2,19,20 VEGF-C binds to a re-
ceptor named VEGFR-3 (flt-4),10 which is, in adult life,
expressed by the lymphatic endothelium but is not
restricted to it.31 Studies have demonstrated that this
receptor is up-regulated in blood vessels in carci-
noma,32 however, indicating that either blood vessels or
lymphatic vessels can respond to a VEGF-C stimulus,
as both express the receptor for this growth factor.
VEGF-C also binds to VEGFR-2, which is expressed
OOOO ORIGINAL ARTICLE
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the high expression of VEGF-C and the high NMVD in
OCSCC may represent an important mechanism that
differs from lip cancer and perhaps contributes to the
difference in behavior between them.
In addition, our results demonstrated that the positive
expression of VEGF-C is associated with NMVD in
OCSCC in the tumor parenchyma and stroma, sepa-
rately. This is in good agreement with the observation
that tumor cells and their microenvironment may pro-
duce VEGF-C. Previous studies also found that neo-
plastic cells of OSCC may produce VEGF11,33 and,
more specifically, VEGF-C.30 Our results also indicate
that the tumor microenvironment may contribute to
neovascularization. In line with this, the involvement of
chemokines released by cells in the neighborhood of
the tumor with tumoral angiogenesis has been reported
by some authors.34,35 Interestingly, our group found a
higher expression of stromal cell–derived factor-1
(SDF-1\CXCL12) and monocyte chemoattractant pro-
tein-1 (MCP-1\CCL2) in OCSCC when compared with
LSCC36,37 and a correlation of these chemokines with
NMVD and VEGF expression was shown in different
types of cancer.34,35 Thus, taking our previous results
and these related findings together, we can suggest a
possible role of these chemokines in the higher expres-
sion levels of VEGF-C and NMVD in oral cavity
cancer when compared with lip cancer. These works
support the idea that some cells in the tumor microen-
vironment play an important role in cancer behavior.
In conclusion, our results show OCSCC with a
higher expression of VEGF-C and a greater NMVD
than SCC of the lip, which may contribute to the worse
biological behavior of the SCC in the oral cavity. We
also suggest that the different etiologic factors involved
may have a fundamental role in the distinct neovascu-
larization observed in oral cavity and lip cancers. In
addition, both the tumor itself and its microenviron-
ment may influence neovessel formation via the expres-
sion of VEGF-C.
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